ANDREW BRIANE ADAMS, MD, PHD
Radiology in Atlanta, GA
License number
Georgia 64170
Category
Radiology
Type
Transplant Surgery
Address
Address
5105 Wmrb, Atlanta, GA 30322
Phone
(404) 712-1820
(404) 727-3660 (Fax)
(404) 727-3660 (Fax)
Personal information
See more information about ANDREW BRIANE ADAMS at radaris.comName
Address
Phone
430 Ansher Ct, Roswell, GA 30075
4233 Pond Edge Rd, Snellville, GA 30039
Professional information
See more information about ANDREW BRIANE ADAMS at trustoria.com
Dr. Andrew B Adams, Atlanta GA - MD (Doctor of Medicine)
Dr. Andrew B Adams, Atlanta GA - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
101 Woodruff Cir, Atlanta 30322
(404) 712-1820 (Phone), (404) 727-3660 (Fax)
EMORY CLINIC
1365 Clifton Rd NE SUITE B, Atlanta 30322
(404) 778-7777 (Phone), (404) 778-5128 (Fax)
(404) 712-1820 (Phone), (404) 727-3660 (Fax)
EMORY CLINIC
1365 Clifton Rd NE SUITE B, Atlanta 30322
(404) 778-7777 (Phone), (404) 778-5128 (Fax)
Procedures:
Excision of Bile Duct Tumor, Hepatectomy, Inguinal Hernia Repair, Open, Intestinal Transplant (incl. Enterectomy), Liver Transplant, Pancreatectomy (incl. Pancreas Transplant & Whipple Procedure), Renal Transplant and Nephrectomy
Conditions:
Esophageal Varices, Liver Cancer, Umbilical Hernia
Languages:
English
Education:
Medical School
Emory University
Graduated: 2001
Emory University
Graduated: 2001
Personal Risk Manager At Wachovia Insurance
Personal Risk Manager At Wachovia Insurance
Position:
Personal Risk Manager at Wachovia Insurance
Location:
Greater Atlanta Area
Industry:
Insurance
Work:
Wachovia Insurance
-
Personal Risk Manager
Education:
University of Georgia - Terry College of Business 2002 - 2006
Management, Spanish
Management, Spanish
Andrew Briane Adams, Atlanta GA
Andrew Briane Adams, Atlanta GA
Specialties:
Surgeon
Address:
1365 Clifton Rd Ne, Atlanta, GA 30322
1364 Clifton Rd Ne, Atlanta, GA 30322
1364 Clifton Rd Ne, Atlanta, GA 30322
Methods For Protecting Allogeneic Islet Transplant Using Soluble Ctla4 Mutant Molecules
Methods For Protecting Allogeneic Islet Transplant Using Soluble Ctla4 Mutant Molecules
US Patent:
7829534, Nov 9, 2010
Filed:
Oct 29, 2007
Appl. No.:
11/978701
Inventors:
Christian P. Larsen - Atlanta GA, US
Thomas C. Pearson - Atlanta GA, US
Andrew B. Adams - Atlanta GA, US
Robert J. Peach - San Diego CA, US
Peter S. Linsley - Seattle WA, US
Joseph Roy Naemura - Bellevue WA, US
Jurgen Bajorath - Bonn, DE
Thomas C. Pearson - Atlanta GA, US
Andrew B. Adams - Atlanta GA, US
Robert J. Peach - San Diego CA, US
Peter S. Linsley - Seattle WA, US
Joseph Roy Naemura - Bellevue WA, US
Jurgen Bajorath - Bonn, DE
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 38/16, C07K 14/705, C07K 16/46
US Classification:
514 12, 4241341, 530350, 5303873
Abstract:
The present invention is a method of inhibiting islet cell transplant rejection particular, to treat diabetes, such as type-1 and type-2 diabetes, by administering to a subject an effective amount of a soluble CTLA4 mutant molecule. One example of soluble CTLA4 mutant molecule is L104EA29YIg.
Methods For Protecting Allogeneic Islet Transplant Using Soluble Ctla4 Mutant Molecules
Methods For Protecting Allogeneic Islet Transplant Using Soluble Ctla4 Mutant Molecules
US Patent:
7304033, Dec 4, 2007
Filed:
May 23, 2002
Appl. No.:
10/155514
Inventors:
Christian P. Larsen - Atlanta GA, US
Thomas C. Pearson - Atlanta GA, US
Andrew B. Adams - Atlanta GA, US
Robert J. Peach - San Diego CA, US
Peter S. Linsley - Seattle WA, US
Joseph Roy Naemura - Bellevue WA, US
Jurgen Bajorath - Bonn, DE
Thomas C. Pearson - Atlanta GA, US
Andrew B. Adams - Atlanta GA, US
Robert J. Peach - San Diego CA, US
Peter S. Linsley - Seattle WA, US
Joseph Roy Naemura - Bellevue WA, US
Jurgen Bajorath - Bonn, DE
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 38/16, C07K 14/00
US Classification:
514 12, 4241341, 530350, 5303873
Abstract:
The present invention is a method of inhibiting islet cell transplant rejection, particularly to treat diabetes, such as type-1 and type-2 diabetes, by administering to a subject an effective amount of a soluble CTLA4 mutant molecule. One example of a soluble CTLA4 mutant molecule is L104EA29YIg.
Methods Of Inducing Organ Transplant Tolerance And Correcting Hemoglobinopathies
Methods Of Inducing Organ Transplant Tolerance And Correcting Hemoglobinopathies
US Patent:
2003000, Jan 9, 2003
Filed:
Jan 25, 2002
Appl. No.:
10/057288
Inventors:
Christian Larsen - Atlanta GA, US
Thomas Pearson - Atlanta GA, US
Edmund Waller - Atlanta GA, US
Andrew Adams - Atlanta GA, US
Thomas Pearson - Atlanta GA, US
Edmund Waller - Atlanta GA, US
Andrew Adams - Atlanta GA, US
International Classification:
A61K039/395, A61K031/255, A61K045/00
US Classification:
424/144100, 424/093700, 514/517000
Abstract:
Methods of establishing hematopoietic chimerism useful to correct hematological diseases and promote acceptance of organ transplants include administering busulfan, costimulation blockade, and readily attainable numbers of T-cell depleted bone marrow cells.
Umpire At Southern Collegiate Umpires
Umpire At Southern Collegiate Umpires
Position:
Umpire at Southern Collegiate Umpires
Location:
Greater Atlanta Area
Industry:
Sports
Work:
Southern Collegiate Umpires
-
Umpire
Andrew Monroe Adams, Atlanta GA - Lawyer
Andrew Monroe Adams, Atlanta GA - Lawyer
Address:
3105 Clairmont Rd, Atlanta 30329
Licenses:
Georgia - Active Member in Good Standing 2008
Education:
Georgia State University